- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in New Zealand
Total 1712 results
-
RWTH Aachen UniversityUnknownObesity | Bariatric Surgery Candidate | Nonalcoholic SteatohepatitisGermany
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Viking Therapeutics, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Madrigal Pharmaceuticals, Inc.RecruitingNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
New Discovery LLCNYU Langone Health; Stanford University; Baylor University; Rush University; Wuxi...RecruitingFatty Liver | Liver FibrosisUnited States
-
Yale UniversityAmerican Heart AssociationTerminatedNon Alcoholic Fatty Liver DiseaseUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Genentech, Inc.CompletedDiabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver DiseaseUnited States, Canada
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico
-
Far Eastern Memorial HospitalCompletedObesity | Fatty LiverTaiwan
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
Aligos TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated SteatohepatitisUnited States
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American...CompletedFatty Liver | Hepatic SteatosisUnited States
-
Columbia UniversityActive, not recruitingPolycystic Ovary Syndrome | Metabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
Columbia UniversityActive, not recruitingPolycystic Ovary Syndrome | Metabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
Far Eastern Memorial HospitalNational Taiwan University HospitalUnknown
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Dalin Tzu Chi General HospitalUnknownLiver Diseases | Progression | Hepatitis B | Hepatocellular Carcinoma | Hepatitis C | Carcinogenesis | Liver Cirrhoses | Fatty Liver Disease | Treatment Outcome | HumansTaiwan
-
Alios Biopharma Inc.Completed
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Jeffrey L Zitsman, MDCompletedObstructive Sleep Apnea Syndrome | Metabolic Syndrome | Insulin Resistance | Morbid Obesity | Nonalcoholic Fatty Liver DiseaseUnited States